FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 19:27:02 13/05/2024 BST | ||
| 4.17 EUR | -7.95% |
|
| Current month | +2.03% | ||
| 1 month | -35.01% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/24 | 4.17 | -7.95% | 0 |
| 10/05/24 | 4.53 | -1.09% | 0 |
| 09/05/24 | 4.58 | -3.98% | 0 |
| 08/05/24 | 4.77 | -2.85% | 0 |
| 07/05/24 | 4.91 | +2.51% | 0 |
Real-time BOERSE MUENCHEN
Last update May 13, 2024 at 07:27 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG3BMX |
| ISIN | DE000GG3BMX4 |
| Date issued | 01/02/2024 |
| Strike | 166.1 $ |
| Maturity | Unlimited |
| Parity | 5.88 : 1 |
| Emission price | 8.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.58 € |
|---|---|
| Lowest since issue | 4.17 € |
| Spread | 0.07 € |
| Spread % | 1.67% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat
